Genetic determinants of lipid aberrations in patents with essential hypertension

Genetic determinants of lipid aberrations in patents with essential hypertension

Aim. To reveal the relationship between apolipoprotein E gene polymorphism and lipid spectrum modification in patients with essential hypertension. Materials and methods. The lipid spectrum components and apolipoprotein E gene polymorphism were analyzed in 310 patients with essential hypertension...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. V. Buriak, V. A. Vizir, O. V. Demidenko
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2020-04-01
Series:	Zaporožskij Medicinskij Žurnal
Subjects:	apolipoprotein e genetic polymorphism essential hypertension dyslipidemia
Online Access:	http://zmj.zsmu.edu.ua/article/view/200564/201018
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

APOLIPOPROTEIN A1 GENE AND ITS ROLE IN DYSLIPIDEMIA DEVELOPMENT ACROSS ETHNIC GROUPS OF PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
by: T. A. Bairova, et al.
Published: (2012-12-01)

Polymorphism of the second type angiotensin II receptor’s gene in women with essential hypertension and the corresponding features of structural and functional parameters of myocardium
by: O. O. Sakovych, et al.
Published: (2018-08-01)

Influence of additional risk factors on the antihypertensive efficacy of eprosartan and telmisartan in patients with essential hypertension
by: V. V. Syvolap, et al.
Published: (2017-12-01)

ESSENTIAL SYSTEMIC HYPERTENSION: GENETICS, CLINICS, EXPERIMENT
by: А. L. Markel
Published: (2017-11-01)

The association between aldosterone and lipid profiles in patients with primary aldosteronism
by: Ning-Peng Liang, et al.
Published: (2025-03-01)

Features of arterial hypertension course in patients with psoriasis
by: V. A. Vizir, et al.
Published: (2017-04-01)

The association of blood pressure and hypertension with genetic markers identified in genome-wide association studies
by: S. K. Malyutina, et al.
Published: (2018-11-01)

Cardiovascular aspects and the state of vegetative balance in patients with arterial hypertension associated with dyslipidemia
by: O. V. Vizir-Tronova
Published: (2017-10-01)

Effect of Hyperbaric Oxygen Treatment on Lipid Metabolism and Neurovascular Microenvironment in an Apolipoprotein E Knockout Mouse Model
by: Guoying Dong, et al.
Published: (2025-07-01)

Anti-remodeling efficacy of eprosartan in patients with essential hypertension, and gene polymorphism of angiotensin II type 1 receptors
by: B. Sh. Karimova, et al.
Published: (2005-02-01)

Contribution of Rare and Common <i>APOE</i> Variants to Familial Hypercholesterolemia in Spanish Cohort
by: Lorena M. Vega-Prado, et al.
Published: (2025-01-01)

ASSOCIATION OF THE GENE CYP11B2 WITH THE RISK OF ESSENTIAL HYPERTENSION AND ATHEROTHROMBOTIC COMPLICATIONS
by: E. M. Zelenskaya, et al.
Published: (2016-06-01)

CHANGES IN PLASMA LIPID COMPOSITION IN PATIENTS WITH ESSENTIAL HYPERTENSION
by: A. V. Govorin, et al.
Published: (2003-06-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM GENES POLYMORPHISM AND RELATION WITH VASOPRESSORS IN ESSENTIAL HYPERTENSION AMONG DAGESTAN INHABITANTS
by: M. Z. Saidov, et al.
Published: (2017-05-01)

Association of IL-1RAcP rs16865597 gene polymorphism with susceptibility to essential hypertension: a case-control study in the Chinese Han population
by: Fangqin Wu, et al.
Published: (2025-03-01)

Tumor necrosis factor alpha gene polymorphism in patients wiht essential hypertension
by: Y. R. Timasheva, et al.
Published: (2007-12-01)

Hemorheological parameters in patients with arterial hypertension and lipid metabolism disorders
by: E. D. Abrashkina, et al.
Published: (2010-02-01)

Gender peculiarities of epidemiology and clinical course in patients with psoriasis associated with arterial hypertension
by: G. I. Makurina, et al.
Published: (2015-10-01)

Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins
by: M. A. Kachkovsky, et al.
Published: (2020-12-01)

Angiotensin Converting Enzyme 2 (ACE2) G8790A Gene Polymorphism as a Risk Factor for Essential Hypertension
by: Nazaul Husna, et al.
Published: (2025-08-01)

Relationship between psoriasis severity degree and TNF-α levels in patients with psoriasis in combination with arterial hypertension
by: V. P. Fedotov, et al.
Published: (2015-06-01)

Clinical study of APOE gene polymorphism combined with atorvastation in the treatment of chronic subdural hematoma
by: TAN Bao-dong, et al.
Published: (2025-06-01)

ON THE GENETIC REGULATION OF BRAIN NATRIURETIC PEPTIDE LEVEL IN PLASMA OF MEN WITH ESSENTIAL HYPERTENSION
by: I. P. Pashkovа, et al.
Published: (2017-03-01)

The efficacy of diuretics in complex treatment of patients with hypertension according to the Gly460Trp polymorphism of the α-adducin gene
by: S. A. Yermolenko, et al.
Published: (2021-07-01)

METABOLIC DISTURBANCES IN THE FUTURE DEVELOPMENT AND PROGRESSION OF ARTERIAL HYPERTENSION IN YOUNG MEN
by: A. V. Gordienko, et al.
Published: (2015-08-01)

Apolipoprotein E gene polymorphisms as risk factors for carotid atherosclerosis
by: Zurnić Irena, et al.
Published: (2014-01-01)

Apolipoprotein-b gen and its role in formation of essential hypertension
by: L. I. Kolesnikova, et al.
Published: (2015-11-01)

Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
by: Z. D. Kobalava, et al.
Published: (2020-11-01)

INHERITANCE OF POLYMORPHIC GENOTYPES OF THE ENDOTHELIN-1 GENE AND INDICATORS OF CARDIAC AND SYSTEMIC HEMODYNAMICS IN MEN WITH ESSENTIAL HYPERTENSION, RESIDENTS OF PODILLYA
by: H.O. Palahniuk, et al.
Published: (2017-03-01)

PREDICTING PRECLINICAL THROMBOGENIC ABNORMALITIES IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
by: S. S. Bunova, et al.
Published: (2013-04-01)

Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER
by: I. A. Zolotovskaya, et al.
Published: (2022-07-01)

Features of the pro-inflammatory activation and its role in the pathogenesis of cardiovascular remodeling in hypertensive patients of the ii nd stage
by: V. A. Vizir, et al.
Published: (2013-08-01)

Combinations of NOS3 and CYBA alleles and essential hypertension risk in men
by: P. I. Makarevich, et al.
Published: (2010-06-01)

Polymorphism of PPARG (P12A), APOA1 (G75A), and APOE (C112A and A158C) Genes in Children with Obesity and Arterial Hypertension: A Case-Control Study
by: Olga P. Kovtun, et al.
Published: (2018-10-01)

Impaired Choroidal Blood Flow in Adolescents with Essential Arterial Hypertension
by: Yu. N. Savina, et al.
Published: (2019-08-01)

Effective polypill therapy in patients with hypertension and dyslipidemia
by: V. E. Oleynikov, et al.
Published: (2025-07-01)

Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetes
by: Chao Zuo, et al.
Published: (2025-07-01)

Multiple Bio-Computational Tools Emerge as Valid Approach in the Assessment of Apolipoproteins Pathogenicity Related Mutations
by: Giorgia Francesca Saraceno, et al.
Published: (2025-03-01)

NUTRITCIOGENETICS AND RISK FACTORS OF CARDIOVASCULAR DISEASE: ASSOCIATED RESEARCH IN EASTERN SIBERIA POPULATIONS
by: T. A. Bairova, et al.
Published: (2013-07-01)

Structural and functional status of myocardium and signal-averaged electrocardiogram data in essential arterial hypertension patients
by: V. I. Ruzov, et al.
Published: (2005-12-01)